This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Addison, W. R.
Right arrow Articles by Tyrrell, D. L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Addison, W. R.
Right arrow Articles by Tyrrell, D. L. J.

 Previous Article  |  Next Article 

Journal of Virology, June 2002, p. 6356-6363, Vol. 76, No. 12
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.12.6356-6363.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Half-Life of the Duck Hepatitis B Virus Covalently Closed Circular DNA Pool In Vivo following Inhibition of Viral Replication

William R. Addison,1* Kathie-Anne Walters,1 Winnie W. S. Wong,2 John S. Wilson,1 Danuta Madej,1 Lawrence D. Jewell,3 and D. Lorne J. Tyrrell1,2

Department of Medical Microbiology and Immunology and Glaxo Wellcome Research Centre, University of Alberta, Edmonton, Alberta, Canada T6G 2S2,1 Department of Medicine,2 Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada T6G 2R73

Received 10 January 2002/ Accepted 16 March 2002

Covalently closed circular DNA (cccDNA) is a crucial intermediate in the replication of hepadnaviruses. We inhibited the replication of duck hepatitis B virus in congenitally infected ducks with a combination of lamivudine and a dideoxyguanosine prodrug. Inhibition of viral replication should prevent renewal of the cccDNA pool, and its decay was measured in liver biopsy samples collected over a 5-month period. In three ducks, the cccDNA pools declined exponentially, with half-lives ranging from 35 to 57 days. In two others, the pools declined exponentially for about 70 days but then stabilized at about 6 copies/diploid genome. The selection of drug-resistant virus mutants is an unlikely explanation for this unexpected stabilization of cccDNA levels. Liver sections stained for the cell division marker PCNA showed that animals in which cccDNA loss was continuous had significantly greater numbers of PCNA-positive nuclei than did those animals in which cccDNA levels had plateaued.

* Corresponding author. Mailing address: Department of Medical Microbiology and Immunology, 622 HMRC, University of Alberta, Edmonton, Alberta, Canada T6G 2S2. Phone: (780) 492-7227. Fax: (780) 492-9828. E-mail: bill.addison{at}ualberta.ca.

Journal of Virology, June 2002, p. 6356-6363, Vol. 76, No. 12
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.12.6356-6363.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Thermet, A., Buronfosse, T., Werle-Lapostolle, B., Chevallier, M., Pradat, P., Trepo, C., Zoulim, F., Cova, L. (2008). DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infection. J. Gen. Virol. 89: 1192-1201 [Abstract] [Full Text]  
  • Wang, R. Y.-L., Shen, C.-N., Lin, M.-H., Tosh, D., Shih, C. (2005). Hepatocyte-Like Cells Transdifferentiated from a Pancreatic Origin Can Support Replication of Hepatitis B Virus. J. Virol. 79: 13116-13128 [Abstract] [Full Text]  
  • Anderson, A. L., Banks, K. E., Pontoglio, M., Yaniv, M., McLachlan, A. (2005). Alpha/Beta Interferon Differentially Modulates the Clearance of Cytoplasmic Encapsidated Replication Intermediates and Nuclear Covalently Closed Circular Hepatitis B Virus (HBV) DNA from the Livers of Hepatocyte Nuclear Factor 1{alpha}-Null HBV Transgenic Mice. J. Virol. 79: 11045-11052 [Abstract] [Full Text]  
  • Summers, J., Mason, W. S. (2004). Residual integrated viral DNA after hepadnavirus clearance by nucleoside analog therapy. Proc. Natl. Acad. Sci. USA 101: 638-640 [Abstract] [Full Text]  
  • Walters, K.-A., Tipples, G. A., Allen, M. I., Condreay, L. D., Addison, W. R., Tyrrell, L. (2003). Generation of Stable Cell Lines Expressing Lamivudine-Resistant Hepatitis B Virus for Antiviral-Compound Screening. Antimicrob. Agents Chemother. 47: 1936-1942 [Abstract] [Full Text]  
  • Karayiannis, P. (2003). Hepatitis B virus: old, new and future approaches to antiviral treatment. J Antimicrob Chemother 51: 761-785 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»